No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects.
Saved in:
| Title: | No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects. |
|---|---|
| Authors: | Hollander EM; Department of Pharmacy, Pharmacology and Toxicology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Buma AIG; Department of Pulmonology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Leentjens J; Department of Internal Medicine, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Janssen PKC; Department of Hospital Pharmacy, VieCuri Medical Center, Venlo, the Netherlands., van den Heuvel MM; Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Burger DM; Department of Pharmacy, Pharmacology and Toxicology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Piet B; Department of Pulmonology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Ter Heine R; Department of Pharmacy, Pharmacology and Toxicology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands. |
| Source: | International journal of cancer [Int J Cancer] 2026 Jun 01; Vol. 158 (11), pp. 2920-2927. Date of Electronic Publication: 2026 Jan 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41552958 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hollander+EM%22">Hollander EM</searchLink>; Department of Pharmacy, Pharmacology and Toxicology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Buma+AIG%22">Buma AIG</searchLink>; Department of Pulmonology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Leentjens+J%22">Leentjens J</searchLink>; Department of Internal Medicine, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Janssen+PKC%22">Janssen PKC</searchLink>; Department of Hospital Pharmacy, VieCuri Medical Center, Venlo, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Heuvel+MM%22">van den Heuvel MM</searchLink>; Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Burger+DM%22">Burger DM</searchLink>; Department of Pharmacy, Pharmacology and Toxicology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Piet+B%22">Piet B</searchLink>; Department of Pulmonology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ter+Heine+R%22">Ter Heine R</searchLink>; Department of Pharmacy, Pharmacology and Toxicology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2026 Jun 01; Vol. 158 (11), pp. 2920-2927. <i>Date of Electronic Publication: </i>2026 Jan 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41552958 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ijc.70326 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2920 Titles: – TitleFull: No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hollander EM – PersonEntity: Name: NameFull: Buma AIG – PersonEntity: Name: NameFull: Leentjens J – PersonEntity: Name: NameFull: Janssen PKC – PersonEntity: Name: NameFull: van den Heuvel MM – PersonEntity: Name: NameFull: Burger DM – PersonEntity: Name: NameFull: Piet B – PersonEntity: Name: NameFull: Ter Heine R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1097-0215 Numbering: – Type: volume Value: 158 – Type: issue Value: 11 Titles: – TitleFull: International journal of cancer Type: main |
| ResultId | 1 |